FBIO Earnings Fortress Biotech, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–25 of 25
| Q2 2026 | 2026-06-30 | 2.86 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | 2.82 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -0.07 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | 0.14 | 2025-11-14 | 10-Q |
| Q2 2026 | 2025-06-30 | 0.02 | 2026-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.48 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -2.69 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -2.43 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.76 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.04 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -8.47 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -7.94 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -7.14 | 2024-08-13 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.21 | 2023-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -15.97 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -11.15 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.47 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.18 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -0.79 | 2023-03-31 | 10-K |
| Q3 2022 | 2021-09-30 | -0.41 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.15 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.11 | 2022-05-12 | 10-Q |
| Q1 2020 | 2020-03-31 | -0.19 | 2020-05-11 | 10-Q |
| Q1 2020 | 2019-03-31 | 0.02 | 2020-05-11 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.49 | 2019-05-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.